Adverse event profiles of apalutamide, enzalutamide, and darolutamide in SPARTAN, PROSPER, and ARAMIS: How confident are we about which drug is safest? Meeting Abstract


Authors: Drago, J. Z.; Kantoff, P. W.; Stopsack, K. H.
Abstract Title: Adverse event profiles of apalutamide, enzalutamide, and darolutamide in SPARTAN, PROSPER, and ARAMIS: How confident are we about which drug is safest?
Meeting Title: 2020 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 6 Suppl.
Meeting Dates: 2020 Feb 13-15
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-02-20
Language: English
ACCESSION: WOS:000529525900357
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.6_suppl.318
Notes: Meeting Abstract: 318 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Philip Wayne Kantoff
    197 Kantoff
  2. Joshua Drago
    27 Drago